Form 8-K CAPRICOR THERAPEUTICS, For: May 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Capricor Therapeutics (CAPR) PT Raised to $25 at Ladenburg Thalmann
May 14, 2024 6:46 AM EDTLadenburg Thalmann analyst Aydin Huseynov raised the price target on Capricor Therapeutics (NASDAQ: CAPR) to $25.00 (from $24.00) while maintaining a Buy rating.
The analyst comments "CAPR seems to have advanced in its regulatory negotiations with the FDA with possible rolling BLA... More
